Advertisement
Research Article| Volume 306, ISSUE 1-2, P9-15, July 15, 2011

Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice

  • Susan S. Kim
    Correspondence
    Correspondence to: S. Kim, 1515 Newton Court, Room 510, Davis, CA 95618, United States. Tel.: +1 530 754 5013; fax: +1 530 754 5036.
    Affiliations
    Department of Neurology and Neuroscience Graduate Program, University of California Davis, Davis, CA, United States
    Search for articles by this author
  • David P. Richman
    Affiliations
    Department of Neurology and Neuroscience Graduate Program, University of California Davis, Davis, CA, United States
    Search for articles by this author
  • Scott S. Zamvil
    Correspondence
    Correspondence to: S. Zamvil, Department of Neurology, University of California, San Francisco, 513 Parnassus Avenue, S-268, San Francisco, CA 94143, United States. Tel.: +1 415 502 7395; fax: +1 415 502 8512.
    Affiliations
    Department of Neurology and Program in Immunology, University of California, San Francisco, San Francisco, CA, United States
    Search for articles by this author
  • Mark A. Agius
    Affiliations
    Department of Neurology and Neuroscience Graduate Program, University of California Davis, Davis, CA, United States

    Veterans Administration Northern California Health Care System, Mather, CA, United States
    Search for articles by this author
Published:April 29, 2011DOI:https://doi.org/10.1016/j.jns.2011.04.008

      Abstract

      B cell activating factor (BAFF) is critical for B cell survival, a function that is mediated by BAFF receptor, (BAFF-R). The role of BAFF (or BAFF-R) in the multiple sclerosis model, experimental autoimmune encephalomyelitis (EAE), was examined using BAFF-R-deficient mice. BAFF-R deficiency resulted in paradoxically increased severity of EAE induced by myelin-oligodendrocyte glycoprotein (MOG) peptide 35–55. Inflammatory foci in BAFF-R-deficient mice comprised increased numbers of activated macrophages expressing BAFF and correlated with increased BAFF secretion. Thus, BAFF-R may be important in EAE pathogenesis, possibly by influencing macrophage function through a mechanism that involves modulation of BAFF expression.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lyons J.A.
        • Ramsbottom M.J.
        • Cross A.H.
        Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.
        Eur J Immunol. 2002 Jul; 32: 1905-1913
        • Lassmann H.
        • Bruck W.
        • Lucchinetti C.F.
        The immunopathology of multiple sclerosis: an overview.
        Brain pathology (Zurich, Switzerland). 2007 Apr; 17 (210–8)
        • Weiner H.L.
        Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease.
        Arch Neurol. 2004 Oct; 61: 1613-1615
        • Rammohan K.W.
        • Shoemaker J.
        Emerging multiple sclerosis oral therapies.
        Neurology. 2010 Jan 5; 74: S47-S53
        • Thompson J.S.
        • Bixler S.A.
        • Qian F.
        • Vora K.
        • Scott M.L.
        • Cachero T.G.
        • et al.
        BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF.
        Science. 2001 Sep 14; 293: 2108-2111
        • Gross J.A.
        • Johnston J.
        • Mudri S.
        • Enselman R.
        • Dillon S.R.
        • Madden K.
        • et al.
        TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.
        Nature. 2000 Apr 27; 404: 995-999
        • Nardelli B.
        • Belvedere O.
        • Roschke V.
        • Moore P.A.
        • Olsen H.S.
        • Migone T.S.
        • et al.
        Synthesis and release of B-lymphocyte stimulator from myeloid cells.
        Blood. 2001 Jan 1; 97: 198-204
        • Gorelik L.
        • Gilbride K.
        • Dobles M.
        • Kalled S.L.
        • Zandman D.
        • Scott M.L.
        Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells.
        J Exp Med. 2003 Sep 15; 198: 937-945
        • Sasaki Y.
        • Casola S.
        • Kutok J.L.
        • Rajewsky K.
        • Schmidt-Supprian M.
        TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology.
        J Immunol. 2004 Aug 15; 173: 2245-2252
        • Ng L.G.
        • Sutherland A.P.
        • Newton R.
        • Qian F.
        • Cachero T.G.
        • Scott M.L.
        • et al.
        B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells.
        J Immunol. 2004 Jul 15; 173: 807-817
        • Chang S.K.
        • Arendt B.K.
        • Darce J.R.
        • Wu X.
        • Jelinek D.F.
        A role for BLyS in the activation of innate immune cells.
        Blood. 2006 Oct 15; 108: 2687-2694
        • Jeon S.T.
        • Kim W.J.
        • Lee S.M.
        • Lee M.Y.
        • Park S.B.
        • Lee S.H.
        • et al.
        Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells.
        Immunol Cell Biol. 2010 Feb; 88: 148-156
        • Cua D.J.
        • Sherlock J.
        • Chen Y.
        • Murphy C.A.
        • Joyce B.
        • Seymour B.
        • et al.
        Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.
        Nature. 2003 Feb 13; 421: 744-748
        • Miller D.J.
        • Hayes C.E.
        Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice.
        Eur J Immunol. 1991 May; 21: 1123-1130
        • Miller D.J.
        • Hanson K.D.
        • Carman J.A.
        • Hayes C.E.
        A single autosomal gene defect severely limits IgG but not IgM responses in B lymphocyte-deficient A/WySnJ mice.
        Eur J Immunol. 1992 Feb; 22: 373-379
        • Weber M.S.
        • Prod'homme T.
        • Youssef S.
        • Dunn S.E.
        • Rundle C.D.
        • Lee L.
        • et al.
        Type II monocytes modulate T cell-mediated central nervous system autoimmune disease.
        Nat Med. 2007 Aug; 13: 935-943
        • Schiemann B.
        • Gommerman J.L.
        • Vora K.
        • Cachero T.G.
        • Shulga-Morskaya S.
        • Dobles M.
        • et al.
        An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.
        Science. 2001 Sep 14; 293: 2111-2114
        • Sasaki Y.
        • Derudder E.
        • Hobeika E.
        • Pelanda R.
        • Reth M.
        • Rajewsky K.
        • et al.
        Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation.
        Immunity. 2006 Jun; 24: 729-739
        • Enzler T.
        • Bonizzi G.
        • Silverman G.J.
        • Otero D.C.
        • Widhopf G.F.
        • Anzelon-Mills A.
        • et al.
        Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease.
        Immunity. 2006 Sep; 25: 403-415
        • Lee-Chang C.
        • Lefranc D.
        • Salleron J.
        • Faveeuw C.
        • Allet C.
        • Vermersch P.
        • et al.
        Susceptibility to experimental autoimmune encephalomyelitis is associated with altered B-cell subsets distribution and decreased serum BAFF levels.
        Immunol Lett. 2011 Mar 30; 135: 108-117
        • Fillatreau S.
        • Sweenie C.H.
        • McGeachy M.J.
        • Gray D.
        • Anderton S.M.
        B cells regulate autoimmunity by provision of IL-10.
        Nat Immunol. 2002 Oct; 3: 944-950
        • Weber M.S.
        • Prod'homme T.
        • Patarroyo J.C.
        • Molnarfi N.
        • Karnezis T.
        • Lehmann-Horn K.
        • et al.
        B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.
        Ann Neurol. 2010 Jul 16;